Christian Lohr

Full Professor

Universität Hamburg
Country flagGermany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Christian Lohr is a Full Professor at the University of Hamburg, Germany. His research focuses on neuroinflammation, olfactory processing, and astrocyte physiology, with recent publications exploring topics such as purinergic signaling and the impact of amyloid-beta on the endolysosomal system. He is also involved in studies examining the structural deficits in Shank2 related to neurodevelopmental disorders and the three-dimensional analysis of vascular networks.

Articles (18)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

The disruption of astrocytic catabolic processes contributes to the impairment of amyloid‐β (Aβ) clearance, neuroinflammatory signaling, and the loss of synaptic contacts in late‐onset Alzheimer's disease (AD). While it is known that the posttranslational modifications of Aβ have significant implications on biophysical properties of the peptides, their consequences for clearance impairment are not well understood. It was previously shown that N ‐terminally pyroglutamylated Aβ3(pE)‐42, a significant constituent of amyloid plaques, is efficiently taken up by astrocytes, leading to the release of pro‐inflammatory cytokine tumor necrosis factor α and synapse loss. Here we report that Aβ3(pE)‐42, but not Aβ1‐42, gradually accumulates within the astrocytic endolysosomal system, disrupting this catabolic pathway and inducing the formation of heteromorphous vacuoles. This accumulation alters lysosomal kinetics, lysosome‐dependent calcium signaling, and upregulates the lysosomal stress response. These changes correlate with the upregulation of glial fibrillary acidic protein (GFAP) and increased activity of nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB). Treatment with a lysosomal protease inhibitor, E‐64, rescues GFAP upregulation, NF‐κB activation, and synapse loss, indicating that abnormal lysosomal protease activity is upstream of pro‐inflammatory signaling and related synapse loss. Collectively, our data suggest that Aβ3(pE)‐42‐induced disruption of the astrocytic endolysosomal system leads to cytoplasmic leakage of lysosomal proteases, promoting pro‐inflammatory signaling and synapse loss, hallmarks of AD‐pathology.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (13)

Christa E. Müller

managing director of the pharmaceutical institute

University of Bonn

GERMANY
View details

Daniela Hirnet

senior scientist

Universität Hamburg

GERMANY
View details

Thomas G Oertner

Director

University Medical Center Hamburg-Eppendorf

GERMANY
View details

Manuel A Friese

Director

University Medical Center Hamburg-Eppendorf

GERMANY
View details

Björn-Philipp Diercks

University Medical Center Hamburg-Eppendorf

GERMANY
View details

Katarzyna M. Grochowska

Group Leader

University Medical Center Hamburg-Eppendorf

GERMANY
View details

Fatemeh Hassani Nia

Université libre de Bruxelles (ULB)

BELGIUM
View details

Antonia Beiersdorfer

University of Hamburg

GERMANY
View details

Christine E Gee

Principle Investigator

University Medical Center Hamburg-Eppendorf

GERMANY
View details

Hans-Jürgen Kreienkamp

University Medical Center Hamburg-Eppendorf

GERMANY
View details

Susanne Dobler

Professor

Universität Hamburg

GERMANY
View details

René Werner

University Medical Center Hamburg-Eppendorf

GERMANY
View details

Sönke Harder

-

GERMANY
View details